{"id":780236,"date":"2025-12-16T16:28:01","date_gmt":"2025-12-16T16:28:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=780236"},"modified":"2025-12-16T16:28:01","modified_gmt":"2025-12-16T16:28:01","slug":"dr-cameron-rokhsar-presents-first-large-case-series-on-nonsurgical-treatment-of-lipomas-using-kybella-deoxycholic-acid-injections","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/dr-cameron-rokhsar-presents-first-large-case-series-on-nonsurgical-treatment-of-lipomas-using-kybella-deoxycholic-acid-injections_780236.html","title":{"rendered":"Dr. Cameron Rokhsar Presents First Large Case Series on Non-Surgical Treatment of Lipomas Using Kybella\u00ae (Deoxycholic Acid) Injections"},"content":{"rendered":"<div style=\"float:right;  width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/upload\/2025\/12\/1765834523.jpg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Dr. Cameron Rokhsar Presents First Large Case Series on Non-Surgical Treatment of Lipomas Using Kybella&reg; (Deoxycholic Acid) Injections\" src=\"https:\/\/www.abnewswire.com\/upload\/2025\/12\/1765834523.jpg\" alt=\"Dr. Cameron Rokhsar Presents First Large Case Series on Non-Surgical Treatment of Lipomas Using Kybella&reg; (Deoxycholic Acid) Injections\" width=\"225\" height=\"225\" \/><\/a><\/div>\n<p style=\"text-align: justify;\"><strong>New York, NY &#8211; December 16, 2025 &#8211;<\/strong> In a landmark advancement in minimally invasive dermatologic surgery, Dr. Cameron Rokhsar, double board-certified dermatologist and dermatologic surgeon, will present the first large case series demonstrating the non-surgical treatment of lipomas using Kybella&reg; (deoxycholic acid) at the 2025 Annual Meeting of the American Society for Dermatologic Surgery (ASDS) this November. This marks the first time a large clinical case series on injectable management of lipomas has been accepted by the ASDS &mdash; a major milestone in the evolution of lipoma care.<\/p>\n<p style=\"text-align: justify;\"><strong>A Breakthrough in Non-Surgical Lipoma Management<\/strong><\/p>\n<p style=\"text-align: justify;\"><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/upload\/2025\/12\/a9eff9c5e15db6d8e03703b682e471a6.jpg\" alt=\"\" \/><\/p>\n<p style=\"text-align: justify;\">Lipomas &mdash; benign fatty tumors historically treated through surgical excision &mdash; often leave scars and require recovery time. Dr. Rokhsar&rsquo;s study at the New York Cosmetic Skin &amp; Laser Surgery Center explored the use of Kybella&reg; (deoxycholic acid), an FDA-approved injectable for submental fat reduction, to dissolve lipomas through adipocytolysis &mdash; disruption of fat-cell membranes and natural clearance by macrophages.<\/p>\n<p style=\"text-align: justify;\">Key findings from 20 patients treated for subcutaneous lipomas include:- 60% reported overall satisfaction.- 52.6% observed 50&ndash;100% lipoma size reduction.- Adverse events (bruising, swelling, tenderness) were mild and short-lived.- Most would recommend the treatment, citing no scarring and minimal downtime.<\/p>\n<p style=\"text-align: justify;\">&ldquo;Our results show that deoxycholic acid injections may offer a safe, effective, and scar-free alternative for select patients seeking to treat lipomas without surgery,&rdquo; said Dr. Cameron Rokhsar, Medical Director of the New York Cosmetic Skin &amp; Laser Surgery Center and Clinical Professor of Dermatology at Mount Sinai Hospital. &ldquo;This work broadens the role of injectable fat-dissolving agents from aesthetics into true medical application.&rdquo;<\/p>\n<p style=\"text-align: justify;\"><strong>Study Implications and Next Steps<\/strong><\/p>\n<p style=\"text-align: justify;\">The findings highlight deoxycholic acid&rsquo;s potential as a non-surgical lipolytic therapy. Further controlled studies are planned to refine dosing, assess long-term efficacy, and measure recurrence. The full abstract, &#8216;Non-Surgical Treatment of Lipomas with Deoxycholic Acid: A Large Case Series,&#8217; will be presented at ASDS 2025.<\/p>\n<p style=\"text-align: justify;\"><strong>About Dr. Cameron Rokhsar<\/strong><\/p>\n<p style=\"text-align: justify;\">Dr. Cameron Rokhsar is a board-certified dermatologist and dermatologic surgeon, internationally recognized for pioneering Fraxel&reg; laser resurfacing, non-surgical rhinoplasty, and advanced injectable techniques. He is Medical Director of the New York Cosmetic Skin &amp; Laser Surgery Center and Clinical Professor of Dermatology at Mount Sinai Hospital.<\/p>\n<p style=\"text-align: justify;\">Learn more about Dr. Rokhsar&rsquo;s work in non-surgical lipoma removal at https:\/\/www.cosmeticlaserskinsurgery.com\/lipoma-removal.<\/p>\n<p style=\"text-align: justify;\"><strong>About the American Society for Dermatologic Surgery (ASDS)<\/strong><\/p>\n<p style=\"text-align: justify;\">The ASDS is the leading organization for physicians specializing in skin health and aesthetic surgery, promoting research, education, and innovation in minimally invasive dermatologic care.<\/p>\n<p style=\"text-align: justify;\"><strong>Media Contact:<\/strong><\/p>\n<p style=\"text-align: justify;\">New York Cosmetic Skin &amp; Laser Surgery Center<\/p>\n<p style=\"text-align: justify;\">Attn: Media Relations Team<\/p>\n<p style=\"text-align: justify;\">121 E 60th St, New York, NY 10022<\/p>\n<p style=\"text-align: justify;\">Email: info@cosmeticlaserskinsurgery.com<\/p>\n<p style=\"text-align: justify;\">Website: www.cosmeticlaserskinsurgery.com<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/cosmeticlaserskinsurgery.com_172524.html\" rel=\"nofollow\">New York Cosmetic Skin &#038; Laser Surgery Center<\/a><br \/><strong>Contact Person:<\/strong> Dr. Cameron Rokhsar MD<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=dr-cameron-rokhsar-presents-first-large-case-series-on-nonsurgical-treatment-of-lipomas-using-kybella-deoxycholic-acid-injections\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Address:<\/strong>121 E 60th St  <br \/><strong>City:<\/strong> New York<br \/><strong>State:<\/strong> New York<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"http:\/\/cosmeticlaserskinsurgery.com\" target=\"_blank\" rel=\"nofollow\">cosmeticlaserskinsurgery.com<\/a><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=dr-cameron-rokhsar-presents-first-large-case-series-on-nonsurgical-treatment-of-lipomas-using-kybella-deoxycholic-acid-injections\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>New York, NY &#8211; December 16, 2025 &#8211; In a landmark advancement in minimally invasive dermatologic surgery, Dr. Cameron Rokhsar, double board-certified dermatologist and dermatologic surgeon, will present the first large case series demonstrating the non-surgical treatment of lipomas using &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/dr-cameron-rokhsar-presents-first-large-case-series-on-nonsurgical-treatment-of-lipomas-using-kybella-deoxycholic-acid-injections_780236.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[405,406,420,404],"tags":[],"class_list":["post-780236","post","type-post","status-publish","format-standard","hentry","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-Science","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/780236","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=780236"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/780236\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=780236"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=780236"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=780236"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}